The offer includes a fresh issue of Rs 1,475 crore, along with an offer for sale (OFS) of Rs 2,750 crore. The company submitted its draft papers on August 27, 2024, and received an observation letter from the Securities and Exchange Board of India (Sebi) on November 28.
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY
Laurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-year to Rs 2,206 crore, while